BSX logo

BSX

Boston Scientific Corporation

$105.50
-$0.25(-0.24%)
51
Overall
40
Value
63
Tech
--
Quality
Market Cap
$157.64B
Volume
4.07M
52W Range
$80.50 - $108.94
Target Price
$125.13
Order:

Income Statement

MetricTrendChart
2015
Dec
2016
Dec
2017
Dec
2018
Dec
2019
Dec
2020
Dec
2021
Dec
2022
Dec
2023
Dec
2024
Dec
REVENUE
Total Revenue
$7.5B$8.4B$9.0B$9.8B$10.7B$9.9B$11.9B$12.7B$14.2B$16.7B
Total Revenue
$7.5B$8.4B$9.0B$9.8B$10.7B$9.9B$11.9B$12.7B$14.2B$16.7B
COST OF GOODS SOLD
Cost of Revenue
$2.2B$2.4B$2.6B$2.8B$3.1B$3.5B$3.7B$4.0B$4.3B$5.3B
GROSS PROFIT
Gross Profit
$5.3B$6.0B$6.5B$7.0B$7.6B$6.4B$8.2B$8.7B$9.9B$11.5B
OPERATING EXPENSES
Operating Expenses
$5.6B$5.5B$5.2B$5.5B$6.1B$6.5B$7.0B$6.7B$7.6B$8.9B
Research & Development
$876.0M$920.0M$997.0M$1.1B$1.2B$1.1B$1.2B$1.3B$1.4B$1.6B
Research Expense
$876.0M$920.0M$997.0M$1.1B$1.2B$1.1B$1.2B$1.3B$1.4B$1.6B
Selling, General & Administrative
$2.9B$3.1B$3.3B$3.6B$3.9B$3.8B$4.4B$4.5B$5.2B$6.0B
General & Administrative Expenses
$2.9B$3.1B$3.3B$3.6B$3.9B$3.8B$4.4B$4.5B$5.2B$6.0B
Salaries & Wages
$-28.0M$-29.0M$-32.0M$-21.0M$-24.0M$-28.0M$-29.0M------
Depreciation & Amortization
$495.0M$545.0M$565.0M$599.0M$699.0M$789.0M$741.0M$803.0M$828.0M$856.0M
Depreciation & Amortization
$495.0M$545.0M$565.0M$599.0M$699.0M$789.0M$741.0M$803.0M$828.0M$856.0M
Amortization
$495.0M$545.0M$565.0M$599.0M$699.0M$789.0M$741.0M$803.0M$828.0M$856.0M
Other Operating Expenses
$26.0M$79.0M$68.0M$70.0M$65.0M$45.0M$49.0M$47.0M$46.0M$33.0M
OPERATING INCOME
Operating income
$-327.0M$447.0M$1.3B$1.5B$1.5B$-80.0M$1.2B$1.6B$2.3B$2.6B
EBITDA
$439.0M$1.2B$2.0B$2.6B$2.2B$1.4B$2.5B$2.8B$3.4B$3.9B
NON-OPERATING ITEMS
Interest Expense (Non-Operating)
$284.0M$233.0M$229.0M$241.0M$473.0M$361.0M$341.0M$470.0M$265.0M$305.0M
Net Non-Operating Interest Income/Expense
$-284.0M$-233.0M$-229.0M$-241.0M$-473.0M$-361.0M$-341.0M$460.0M$-265.0M$-305.0M
Gain on Sale of Securities
$2.0M$12.0M------$363.0M$-178.0M------
Other Income/Expense
$181.0M$77.0M$48.0M$-142.0M$428.0M$-2.0M$-62.0M$-434.0M$116.0M$381.0M
Other Special Charges
$-39.0M$-37.0M$-124.0M$156.0M$-358.0M$362.0M$218.0M$-38.0M$-358.0M$-321.0M
SPECIAL ITEMS
Restructring And Mn A Income
$26.0M$28.0M$37.0M$36.0M$38.0M$52.0M$40.0M$24.0M$69.0M$16.0M
Special Income Charges
$-1.1B$-832.0M$-322.0M$-139.0M$-153.0M$-403.0M$-470.0M$-197.0M$42.0M$-16.0M
Impairment of Capital Assets
----------$73.0M--------
PRE-TAX INCOME
EBIT
$-366.0M$410.0M$1.2B$1.7B$1.2B$282.0M$1.4B$1.6B$2.2B$2.6B
Pre-Tax Income
$-650.0M$177.0M$933.0M$1.4B$687.0M$-79.0M$1.1B$1.1B$2.0B$2.3B
INCOME TAX
Tax Provision
$-411.0M$-170.0M$828.0M$-249.0M$-4.0B$2.0M$36.0M$443.0M$393.0M$436.0M
NET INCOME
Net Income
$-239.0M$347.0M$104.0M$1.7B$4.7B$-82.0M$1.0B$698.0M$1.6B$1.9B
Net Income (Continuing Operations)
$-239.0M$347.0M$104.0M$1.7B$4.7B$-115.0M$985.0M$698.0M$1.6B$1.8B
Net Income (Discontinued Operations)
$-239.0M$347.0M$104.0M$1.7B$4.7B$-82.0M$1.0B$698.0M$1.6B$1.9B
Net Income (Common Stockholders)
$-151.0M$347.0M$104.0M$1.7B$4.7B$-115.0M$985.0M$642.0M$1.6B$1.9B
Normalized Income
$212.0M$879.0M$852.5M$1.3B$-3.1B$727.6M--------
TOTALS
Total Expenses
$7.8B$7.9B$7.8B$8.3B$9.2B$10.0B$10.7B$10.6B$11.9B$14.1B
SHARE & EPS DATA
Average Shares Outstanding
$1.3B$1.4B$1.4B$1.4B$1.4B$1.4B$1.4B$1.4B$1.5B$1.5B
Average Shares Outstanding (Diluted)
$1.3B$1.4B$1.4B$1.4B$1.4B$1.4B$1.4B$1.4B$1.5B$1.5B
Shares Outstanding
$1.3B$1.4B$1.4B$1.4B$1.4B$1.4B$1.4B$1.4B$1.5B$1.5B
Basic EPS
$-0.18$0.26$0.08$1.21$3.38$-0.08$0.69$0.45$1.08$1.26
Basic EPS (Continuing Operations)
$-0.18$0.26$0.08$1.21$3.38$-0.08$0.69$0.45$1.08$1.26
Diluted EPS
$-0.18$0.25$0.08$1.19$3.33$-0.08$0.69$0.45$1.07$1.25
Diluted EPS (Continuing Operations)
$-0.18$0.25$0.08$1.19$3.33$-0.08$0.69$0.45$1.07$1.25
OTHER METRICS
Accrued Preferred Stock Dividends
----------$33.0M$55.0M$55.0M$23.0M--
Gain On Sale Of Business
------------$78.0M$-22.0M----
Minority Interests
$6.3B$6.7B$7.0B$8.7B$13.9B$15.3B----$1.0M$8.0M
Non Recurring Operation Expense
$1.1B$804.0M$285.0M$103.0M$115.0M$278.0M$430.0M$173.0M$-111.0M--
Other Gand A
$2.9B$3.1B$3.3B$3.6B$3.9B$3.8B$4.4B$4.5B$5.2B$6.0B
Other Impairment Of Capital Assets
$19.0M$11.0M$4.0M$35.0M$105.0M$460.0M$370.0M$132.0M$58.0M$386.0M
Other Write Off
--------$17.0M$27.0M$25.0M------
Otherunder Preferred Stock Dividend
----------$33.0M$55.0M$55.0M$23.0M--
Preferred Stock Dividends
----------$33.0M$55.0M$55.0M$23.0M--
Rent And Landing Fees
$76.0M$80.0M$88.0M$92.0M$80.0M----------
Write Down
--------$-19.0M----------
Restruct
$26.0M$28.0M$37.0M$36.0M$38.0M$52.0M$40.0M$24.0M$69.0M$16.0M

Financial data is updated quarterly and may not reflect the most recent earnings.

ABCD
1SymbolPriceChangeVol
2BSX$105.50-0.2%4.07M
3
4
5
6

Get Boston Scientific Corporation Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.